The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.
The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.
'
TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS VII
EXECUTIVE SUMMARY 1
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
1.1 KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
1.1 RESEARCH SCOPE 16
1.2 IDATA’S 9-STEP METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis 23
Step 7: Identify Strategic Opportunities 25
Step 8: Final Review and Market Release 26
Step 9: Customer Feedback and Market Monitoring 27
DISEASE OVERVIEW 28
2.1 BASIC ANATOMY 28
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS 29
2.2.1 Gastro-Esophageal Reflux Disease (GERD) 32
2.2.2 Barrett's Esophagus 33
2.2.3 Digestive Cancer 33
2.2.4 Gastrointestinal bleeding 35
2.2.5 Bile Duct Disorders 36
2.2.6 Crohn’s disease 37
2.2.7 Ulcer 37
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction 38
2.3 PATIENT DEMOGRAPHICS 40
2.3.11 Patient Demographics 40
2.3.11.1 All Digestive Diseases 40
2.3.11.2 Abdominal Wall Hernia 42
2.3.11.3 Chronic Constipation 42
2.3.11.4 Diverticular Disease 42
2.3.11.5 Prescriptions 42
2.3.11.6 Gastroesophageal Reflux Disease 43
2.3.11.7 Gastrointestinal Infections 43
2.3.11.8 Hemorrhoids 43
2.3.11.9 Inflammatory Bowel Disease 44
2.3.11.10 Liver Disease 44
2.3.11.11 Pancreatitis 45
2.3.11.12 Peptic Ulcer Diseases 45
2.3.12 Digestive Cancer 46
GASTROINTESTINAL PROCEDURE NUMBERS 49
3.1 LIST OF PROCEDURAL CODES 49
3.2 PROCEDURE OVERVIEW 50
3.2.1 Total Gastrointestinal Device Market Procedures 50
3.2.2 Gastrointestinal Endoscopy Procedures by Segment 54
3.2.2.1 EGD Procedures 54
3.2.2.2 Colonoscopy Procedures 54
3.2.2.3 Sigmoidoscopy Procedures 54
3.2.2.4 Enteroscopy Procedures 54
3.2.2.5 Ultrasound Endoscopy Procedures 55
3.2.2.6 ERCP Procedures 55
3.2.3 Capsule Endoscopy Procedures 59
3.2.4 Virtual Colonoscopy Procedures 61
3.2.5 Stenting Procedures by Segment 63
3.2.5.1 Esophageal Stenting Procedures 63
3.2.5.2 Duodenal Stenting Procedures 63
3.2.5.3 Colonic Stenting Procedures 63
3.2.5.4 Biliary Stenting Procedures 63
3.2.6 Dilation Procedures by Segment 66
3.2.6.1 Esophageal Dilation Procedures 66
3.2.6.2 Duodenal Dilation Procedures 66
3.2.6.3 Colonic Dilation Procedures 66
3.2.6.4 Biliary Dilation Procedures 66
3.2.7 Tissue Biopsy Procedures by Segment 69
3.2.7.1 Biopsy Forceps Procedures 69
3.2.7.2 EUS Needle Procedures 69
3.2.8 Snare, Tumor and Polyp Removal Procedures 71
3.2.9 Specimen Retrieval Procedures 73
3.2.10 Foreign Body Removal Procedures 75
3.2.11 Hemostasis Procedures 77
3.2.12 Enteral Feeding Tube Placement Procedures 79
3.2.13 Anti-Reflux Device Implantation Procedures 81
3.2.14 Barrett's Esophagus Ablation Procedures 83
ABBREVIATIONS 85
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023 2
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023 2
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016 47
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016 47
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016 48
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016 48
Chart 3 1: Total Gastrointestinal Device Market Procedure Numbers, U.S., 2013 – 2023 53
Chart 3 2: Gastrointestinal Endoscopy Procedure Numbers by Segment, U.S., 2013 – 2023 58
Chart 3 3: Capsule Endoscopy Procedure Numbers, U.S., 2013 – 2023 60
Chart 3 4: Virtual Colonoscopy Procedure Numbers, U.S., 2013 – 2023 62
Chart 3 5: Stenting Procedure Numbers by Segment, U.S., 2013 – 2023 65
Chart 3 6: Dilation Procedure Numbers by Segment, U.S., 2013 – 2023 68
Chart 3 7: Tissue Biopsy Procedure Numbers by Segment, U.S., 2013 – 2023 70
Chart 3 8: Snare, Tumor and Polyp Removal Procedure Numbers, U.S., 2013 – 2023 72
Chart 3 9: Specimen Retrieval Procedure Numbers, U.S., 2013 – 2023 74
Chart 3 10: Foreign Body Removal Procedure Numbers, U.S., 2013 – 2023 76
Chart 3 11: Hemostasis Procedure Numbers, U.S., 2013 – 2023 78
Chart 3 12: Enteral Feeding Tube Placement Procedure Numbers, U.S., 2013 – 2023 80
Chart 3 13: Anti-Reflux Device Implantation Procedure Numbers, U.S., 2013 – 2023 82
Chart 3 14: Barrett's Esophagus Ablation Procedure Numbers, U.S., 2013 – 2023 84
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, U.S., 2016 5
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2) 6
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2) 7
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016 8
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 9
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4) 11
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4) 12
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4) 13
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4) 14
Figure 1 13: Key Report Updates 15
Figure 1 14: Version History 15
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009 31
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2) 40
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2) 41
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016 46
Figure 3 1: Procedural Codes Investigated, U.S., 2016 49
Figure 3 2: Procedural Numbers by Segment, U.S., 2016 (1 out of 3) 50
Figure 3 3: Procedural Numbers by Segment, U.S., 2016 (2 out of 3) 51
Figure 3 4: Procedural Numbers by Segment, U.S., 2016 (3 out of 3) 52
Figure 3 5: Gastrointestinal Endoscopy Procedures by Segments, U.S., 2016 (1 of 2) 56
Figure 3 6: Gastrointestinal Endoscopy Procedures by Segments, U.S., 2016 (2 out of 2) 57
Figure 3 7: Capsule Endoscopy Procedure Numbers, U.S., 2013 – 2023 59
Figure 3 8: Virtual Colonoscopy Procedure Numbers, U.S., 2013 – 2023 61
Figure 3 9: Stenting Procedures by Segments, U.S., 2016 (1 out of 2) 63
Figure 3 10: Stenting Procedures by Segments, U.S., 2016 (2 out of 2) 64
Figure 3 11: Dilation Procedures by Segments, U.S., 2016 (1 out of 2) 66
Figure 3 12: Dilation Procedures by Segments, U.S., 2016 (2 out of 2) 67
Figure 3 13: Tissue Biopsy Procedures by Segments, U.S., 2016 69
Figure 3 14: Snare, Tumor and Polyp Removal Procedure Numbers, U.S., 2013 – 2023 71
Figure 3 15: Specimen Retrieval Procedure Numbers, U.S., 2013 – 2023 73
Figure 3 16: Foreign Body Removal Procedure Numbers, U.S., 2013 – 2023 75
Figure 3 17: Hemostasis Procedure Numbers, U.S., 2013 – 2023 77
Figure 3 18: Enteral Feeding Tube Placement Procedure Numbers, U.S., 2013 – 2023 79
Figure 3 19: Anti-Reflux Device Implantation Procedure Numbers, U.S., 2013 – 2023 81
Figure 3 20: Barrett's Esophagus Ablation Procedure Numbers, U.S., 2013 – 2023 83
Boston Scientific
Olympus
Medtronic
Cook Medical
Halyard
Medline
Pentax
ConMed
Fujinon
Moog
C. R. Bard
Endogastric
GE Healthcare
Others include: Alcor Scientific, Applied Medical Technologies, BARD, C2 Therapeutics, Capso Vision, ConMed, CSA Medical, Endochoice, ERBE, Genii, GI Supply, Hobbs Medical, Intromedic, Mederi, Medigus, Medivators, Medline, Merit Endotek, Micro-tech Endoscopy, Mobile Instruments, Moog, Northfield Instruments, Philips, Prezio, MedService International, Rendoscopy, Siemens, Steris, Taewoon Medical, Telemed Systems, TeraREcon, Torax, US Endoscopy, Viatronix, Vital Images, and others.
